LAVA Therapeutics NV
LVTXDelisted Nov 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840748
LAVA Therapeutics NV was delisted on Nov 21, 2025; its insiders filed their last Form 4 on Nov 17, 2025; 21 institutions reported holding it in 13F filings for Q3 2025, worth $16.1M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in LAVA Therapeutics NV as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q2 2024
- Shares held
- 3.61M
- −150.0K (−4.0%) vs. Q2 2024
- Total value
- $5.99M
- −$774.8K (−11.5%) vs. Q2 2024
- New holders
- 4
- 3 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 21 | $16.1M |
| Q2 2025 | 19 | $10.6M |
| Q1 2025 | 20 | $10.2M |
| Q4 2024 | 22 | $6.15M |
| Q3 2024 | 21 | $5.99M |
| Q2 2024 | 19 | $6.77M |
| Q1 2024 | 20 | $12.5M |
| Q4 2023 | 14 | $9.22M |
| Q3 2023 | 14 | $8.47M |
| Q2 2023 | 15 | $11.7M |
| Q1 2023 | 19 | $11.2M |
| Q4 2022 | 20 | $26.3M |
| Q3 2022 | 13 | $34.1M |
| Q2 2022 | 17 | $22.8M |
| Q1 2022 | 18 | $35.2M |
| Q4 2021 | 20 | $44.3M |
| Q3 2021 | 19 | $48.6M |
| Q2 2021 | 18 | $95.5M |
| Q1 2021 | 24 | $139.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding LAVA Therapeutics NV; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 51 | $0 | 0.00% | −175−77.4% | Reduced |
| TSFG, LLC | 400 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,072 | $1.78K | 0.00% | +1,072 | New |
| CIBC Private Wealth Group, LLC | 6,000 | $9.96K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 11,124 | $18.5K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 11,890 | $19.7K | 0.00% | +11,890 | New |
| Millennium Management LLC | 12,063 | $20.0K | 0.00% | −14,430−54.5% | Reduced |
| Walleye Capital LLC | 14,762 | $24.5K | 0.00% | −10,913−42.5% | Reduced |
| Citadel Advisors LLC | 17,013 | $28.2K | 0.00% | −49,224−74.3% | Reduced |
| Virtu Financial LLC | 19,103 | $32.0K | 0.00% | +19,103 | New |
| Two Sigma Advisers, LP | 26,900 | $44.7K | 0.00% | −4,800−15.1% | Reduced |
| Morgan Stanley | 36,400 | $60.4K | 0.00% | +20,800+133.3% | Added |
| Susquehanna International Group, LLP | 48,205 | $80.0K | 0.00% | +48,205 | New |
| Tang Capital Management LLC | 53,101 | $88.1K | 0.01% | +47,992+939.4% | Added |
| The PNC Financial Services Group, Inc. | 65,000 | $107.9K | 0.00% | 00.0% | Unchanged |
| Falcon Edge Capital, LP | 87,397 | $145.1K | 0.05% | 00.0% | Unchanged |
| Pathway Financial Advisors LLC | 102,500 | $170.2K | 0.04% | +42,500+70.8% | Added |
| Two Sigma Investments, LP | 102,766 | $170.6K | 0.00% | −9,673−8.6% | Reduced |
| Sphera Funds Management Ltd. | 146,457 | $243.1K | 0.04% | −221,125−60.2% | Reduced |
| Bruce & Co., Inc. | 771,874 | $1.28M | 0.37% | 00.0% | Unchanged |
| Redmile Group, LLC | 2,074,372 | $3.44M | 0.20% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,807−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −400−100.0% | Sold out |